1-(4-Amino-6,7-Dimethoxy-2-Quinazolinyl)-4-{(Tetnaphydro-2-Furanyl)Carbonyl}Piperazine 1-(4-氨基-6,7-二甲氧基-2-喹唑啉基)-4-[(四氢呋喃-2-甲酰基)哌嗪
CAS 63590-64-7 MFCD00072144
化学结构图
SMILES: COC1=CC2C(N)=NC(=NC=2C=C1OC)N1CCN(CC1)C(=O)C1CCCO1
化学属性
| Mol. Formula | C19H25N5O4 |
|---|---|
| Mol. Weight | 387.438 |
别名和识别编码
| Chemical Name | 1-(4-Amino-6,7-Dimethoxy-2-Quinazolinyl)-4-{(Tetnaphydro-2-Furanyl)Carbonyl}Piperazine |
|---|---|
| Chemical Name Translation | 1-(4-氨基-6,7-二甲氧基-2-喹唑啉基)-4-[(四氢呋喃-2-甲酰基)哌嗪 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Vincent J, et al. Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans. J Clin Invest. 1992 Nov;90(5):1763-8.
- [3]. Ju M, et al. Efficacy of combination terazosin and nifedipine therapy in postoperative treatment of distal ureteral stones after transurethral ureteroscopic lithotripsy. J Int Med Res. 2020 Apr;48(4):300060520904851.
- [1]. Michel MC, et al. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate. J Auton Pharmacol. 1996 Feb;16(1):21-8.
- [1]. Michel MC, et al. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate. J Auton Pharmacol. 1996 Feb;16(1):21-8.
- [2]. Vincent J, et al. Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans. J Clin Invest. 1992 Nov;90(5):1763-8.
- [3].
